Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3519 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Impax comments on Opana lawsuit

Endo Pharmaceuticals and Penwest Pharmaceuticals manufacture and market Opana ER for the treatment of moderate to severe pain. Impax’s submission includes a paragraph IV certification stating the company

Nerviano expands partnership with ChemDiv

The hits identified from Nerviano Medical Sciences (NMS) HT screening campaign will be optimized in terms of their potency, selectivity, in-vitro ADME profile with the subsequent progression into